RELI® Safety Insulin Syringe with Fixed Needle, U-100, 0.3 mL, 29G–31G, Sterile – Select Needle Size is designed for precise low-volume U-100 insulin administration while incorporating an integrated safety mechanism to help reduce needlestick exposure.

The RELI® safety insulin syringe family features a fixed needle, low-dead-space unibody design, clearly marked barrel, and clear sliding safety shield with permanent locking action. MYCO describes the safety mechanism as providing immediate needle shielding, with an audible click after the shield is pushed forward and turned to lock. The product family is sterile, single use, non-pyrogenic, and not made with natural rubber latex.

Key Features

Specifications

MYCO confirms both exact 0.3 mL configurations and packaging. FDA confirms sterile, single-use, prescription-device classification and active commercial distribution for the exact MPNs.

Variant Specifications & FDA Device Identifiers

Variant 1 – 29G x 1/2 Inch

FDA confirms the exact device as RELI® Safety Insulin Syringe, 0.3 mL, 29G x 1/2 inch and lists all three device identifiers.

Variant 2 – 31G x 5/16 Inch

FDA AccessGUDID confirms the exact 31G x 5/16 inch configuration and package identifiers.

Variant Options

Attribute: Needle Size

Parent Product Rule

Create:

1 Parent Product → 2 Needle Size Variants

Do not create separate parent products unless MQ later decides to merchandise each gauge independently.

Each variant should retain its own:

• MPN

• Primary DI

• BX Package DI

• CS Package DI

Warnings

• Sterility
  Sterile
• Single Patient
  Yes
• Autoclave Ready
  No